Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic features and efficacy of decitabine-based chemotherapy in elderly patients with acute myeloid leukemia.

Hematology (Amsterdam, Netherlands) - 1 Dec 2021

Wang Bianhong, Guan Wei, Lv Na, Li Ting, Yu Fan, Huang Yuehua, Wang Yanying, Li Lihong, Yu Li

Abstract excerpt

OBJECTIVES: The outcome of elderly acute myeloid leukemia (AML) patients is poor, which was traditionally attributed to patient- and leukemia-related factors. However, studies about the genetic features of these elderly patients have not been integrated and the genetic mechanism of their poor outcome is less known. METHODS: Here, we used next generation sequencing (NGS) to identify the genetic features of elderly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decitabine

Share to Disease-Free Survival

Share to High-Throughput Nucleotide Sequencing

Share to Leukemia, Myeloid, Acute

Share to Neoplasm Proteins

Share to Survival Rate

Source

Identifiers

PMID: 33971800
DOI: 10.1080/16078454.2021.1921434

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic features and efficacy of decitabine-based chemotherapy in elderly patients with acute myeloid leukemia.PMID 33971800Read ↗

Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine-based chemotherapy.Semantic proximity Read ↗

[Molecular Features and Clinical Significance of Acute Myeloid Leukemia in Elderly Patients].Semantic proximity Read ↗

[Comparision of Mutational Spectrum between Elderly and Young Adults with Acute Myeloid Leukemia Based on Next Generation Sequencing].Semantic proximity Read ↗

Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older.Semantic proximity Read ↗

Latest Insights and Progress in the Clinical Management of Elderly Patients with Acute Myeloid Leukemia: From Genetic Advancements to Targeted TreatmentsSemantic proximity Read ↗

Translational Research on Azacitidine Post- Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QOL-ONE Trans-2)Semantic proximity Read ↗

Age-dependent clinical, molecular, and prognostic differences in patients with AML: a retrospective study.Semantic proximity Read ↗

The clinical features and outcomes of elderly patients with acute myeloid leukemia: a real word research.Semantic proximity Read ↗

Genetic alterations and their clinical implications in older patients with acute myeloid leukemia.Semantic proximity Read ↗

Translational Research on Azacitidine Post-Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QOL-ONE Trans-2).Semantic proximity Read ↗

Genetic alteration patterns and clinical outcomes of elderly and secondary acute myeloid leukemia.Semantic proximity Read ↗

The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.